Both MeCP2 loss- and gain- of function cause neurodevelopmental disorders, Rett Syndrome or MECP2 Duplication Syndrome, respectively, which are characterized by severe cognitive, language, and motor impairments. This evidence concerns the gene MECP2 and atypical Rett syndrome.